Skip to content

03759.HK

Pharmaron Beijing Co., Ltd.

HKSE · Healthcare · Biotechnology · CN

HKD 26.98
+0.22%
Ask drillr

Margins

Gross margin
33.4%
EBITDA margin
16.7%
EBIT margin
14.2%
Net margin
11.1%
FCF margin
-1.5%
10.5%
Return on equity
5.5%
Return on assets
9.3%
Return on invested capital
0.52x
Asset turnover
HKD 3.2B
Cash from operations
HKD 2.64
Cash per share

Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026